DNA-probes for the differentiation of Capnocytophaga species

Molecular and Cellular Probes

Volumn 11, Issue 5, 1997, Pages 323-328

  Conrads, G ^a   Mutters, R ^b   Seyfarth, I ^a   Pelz, K ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b NONE

Author keywords

Capnocytophaga spp; Digoxigenin labelling; Oligonucleotides

Indexed keywords

DIGOXIGENIN; OLIGONUCLEOTIDE;

ARTICLE; CAPNOCYTOPHAGA; CELL DIFFERENTIATION; DNA PROBE; DOT HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; TAXONOMY;

CAPNOCYTOPHAGA;

EID: 0031259828     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcpr.1997.0124     Document Type: Article

References (32)

1. Buu-Hol A. Y, Joundy S, Acar J. F. Endocarditis caused byCapnocytophaga ochracea. Journal of Clinical Microbiology. 26:1988;1061-1062.
2. Parenti D. M, Snydman D. R. Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts. Journal of Infectious Diseases. 151:1985;141.
3. Forlenza S. W. Capnocytophaga sepsis: a newly recognised clinical entity in granulocytopenic patients. The Lancet. 1980;567-568.
4. Rubsamen P. E, McLeish W. M, Pflugfelder S, Miller D. Capnocytophaga endophthalmitis. Ophthalmology. 100:1993;456-459.
5. Esteban J, Albalate M, Caramelo C. Peritonitis involving aCapnocytophaga. Journal of Clinical Microbiology. 33:1995;2471-2472.
6. Henzen C, Streit E. Cervical abscess caused byCapnocytophaga ochracea. Schweizerische Medizinische Wochenschrift. 123:1993;1165-1168.
7. Campbell J, Edwards M. Capnocytophaga species infections in children. The Pediatric Infectious Disease Journal. 12:1991;944-948.
8. Font R, Jay V, Misra R, Jones D, Wilhelmus K. Capnocytophaga keratitis: a clinicopathologic study of three patients, including electron microscopic observations. Ophthalmology. 101:1994;1929-1934.
9. Griego R. D, Rosen T, Orengo I. F, Wolf J. E. Dog, cat, and human bites: a review. Journal of the American Academy of Dermatology. 33:1995;1019-1029.
10. Pers C, Gahm-Hansen B, Frederiksen W. Capnocytophaga canimorsus septicemia in Denmark, 1982-1995: review of 39 cases. Clinical Infectious Diseases. 23:1996;71-75.
11. Ehrbar H.-U, Gubler J, Harbarth S, Hirschel B. Capnocytophaga canimorsus sepsis complicated by myocardial infarction in two patients with normal coronary arteries. Clinical Infectious Diseases. 23:1996;335-336.
12. Brenner D. J, Hollis D. G, Fanning R, Weaver R. E. Capnocytophaga canimorsus sp. nov. (formerly CDC Group DF-2), a cause of septicemia following dog bite, andC. cynodegmi. Journal of Clinical Microbiology. 27:1989;231-235.
13. Yamamoto T, Kajiura S, Hirai Y, Watanabe T. Capnocytophaga haemolytica sp. nov. andCapnocytophaga granulosa. International Journal of Systematic Bacteriology. 44:1994;324-329.
14. Murray P. R, Baron E. J, Pfaller M. A, Tenover F. C, Yolken R. H. Manual of Clinical Microbiology (6th edn). Washington: American Society for Microbiology. 1995.
15. Singh N, Anderegg K, Yu V. Resistance ofCapnocytophaga. Clinical Infectious Diseases. 17:1993;284-285.
16. Gomez-Garces J, Alos J, Sanchez J, Gogollos R. Bacteremia by multidrug-resistantCapnocytophaga sputigena. Clinical Microbiology Reviews. 32:1994;1067-1069.
17. Roscoe D. L, Zemcov S. J. V, Thornber D, Wise R, Clarke A. M. Antimicrobial susceptibilities and β-lactamase characterization ofCapnocytophaga. Antimicrobial Agents and Chemotherapy. 36:1992;2197-2200.
18. Sutter V. L, Pyeatt D, Kwok Y. Y. In vitro susceptibility ofCapnocytophaga. Antimicrobial Agents and Chemotherapy. 20:1981;270-271.
19. Forlenza S. W, Newman M. G, Horikoshi A. L, Blachman U. Antimicrobial susceptibility ofCapnocytophaga. Antimicrobial Agents and Chemotherapy. 19:1981;144-146.
20. Rummens J.-L, Gordts B, Van Landuyt H. W. In vitro susceptibility ofCapnocytophaga. Antimicrobial Agents and Chemotherapy. 30:1986;739-742.
21. Hawkey P. M, Smith S. D, Haynes J, Malnick H, Forlenza S. W. In vitro susceptibility ofCapnocytophaga. Antimicrobial Agents and Chemotherapy. 31:1987;331-332.
22. Conrads G, Brauner A. Non-radioactively labelled DNA probes for the detection of periodontopathogenicPrevotellaPorphyromonas. FEMS Immunology and Medical Microbiology. 6:1993;115-120.
23. Conrads G, Lütticken R. Nucleotide sequences of 16S rRNA encoding genes fromCapnocytophaga ochraceaCapnocytophaga sputigenaCapnocytophaga gingivalis. Nucleic Acids Research. 20:1992;5847.
24. Weber D. J, Hansen A. R. Infections resulting from animal bites. Infectious Disease Clinics of North America. 5:1991;663-680.
25. Zumula A, Lipscomb G, Corbett M. Dysgonic fermenter-2: an emerging zoonosis. Quintessenz Journal of Medicine. 68:1988;741-752.
26. Tanner A. Is the specific plaque hypothesis still tenable. Periodontology Today (Guggenheim, B. ed.) Pp. 123-131. Zürich: Karger Basel. 1988.
27. Conrads G, Mutters R, Fischer J, Brauner A, Lütticken R, Lampert F. PCR reaction and dot-blot hybridization to monitor the distribution of oral pathogens within plaque samples of periodontally healthy individuals. Journal of Periodontology. 67:1996;994-1003.
28. Speck H, Kroppenstedt R. M, Mannheim W. Genomic relationship and species differentiation in the genusCapnocytophaga. Zentralblatt für Bakteriologie und Hygiene (International Journal of Medical Microbiology). 266:1987;390-402.
29. Wilson M. J, Wade W. G, Weightman A. J. Restriction fragment length polymorphism analysis of PCR-amplified 16S ribosomal DNA of humanCapnocytophaga. Journal of Applied Bacteriology. 78:1995;394-401.
30. Khwaja K. J, Parish P, Aldred M. J, Wade W. G. Protein profiles ofCapnocytophaga. Journal of Applied Bacteriology. 68:1990;385-390.
31. Frandsen E, Wade W. Differentiation of humanCapnocytophaga. Microbiology. 142:1996;441-448.
32. Giesendorf B. A. J, Quint G. V, Vandamme P, Van Belkum A. Generation of DNA probes for detection of microorganisms by polymerase chain reaction fingerprinting. Zentralblatt für Bakteriologie (International Journal of Medical Microbiology). 283:1996;417-430.